> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Notice Corrected on Flowtuss NDA Withdrawal
- URL: https://www.fdaweb.com/notice-corrected-on-flowtuss-nda-withdrawal/
- Published: 2024-03-14T12:00:00.000Z
- Updated: 2026-09-14T14:25:26.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5156559

*Federal Register* notice: FDA is correcting a 12/18 notice that announced the withdrawal of two NDAs. That notice indicated that the agency was withdrawing NDA 022424, Flowtuss (guaifenesin 200 mg/5 mL and hydrocodone bitartrate 2.5 mg/5 mL) oral solution held by Chartwell RX Sciences. Chartwell has since informed FDA that it did not want the NDA withdrawn and this notice corrects that decision. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-03-14/pdf/2024-05426.pdf?ref=fdaweb.com).